A protease inhibitor from the tick rhipicephalus boophilus microplus attenuated parenchymal destruction in elastase-induced emphysema Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013
Plant proteinase inhibitor from bauhinia bauhinioides attenuates elastase-induced emphysema in mice Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease Year: 2010
Chronic inhalation toxicity study of nebulized alpha1 proteinase inhibitor (alpha1 -PI), TAL6005, in rodents Source: Annual Congress 2010 - Models of airways disease Year: 2010
Plant proteinase from bauhinia bauhinioides kallikrein inhibitor (BbKI) attenuates inflammation and remodelling induced by elastase in mice Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013
Anti-inflammatory effects of the JAK inhibitor tofacitinib in two murine house dust mite -driven models of asthma. Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018
BmTI-A, a serine protease inhibitor, reduces the chronic allergic lung inflammation in a mice model Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015
BmTI-A: A serine protease inhibitor attenuates hyperresponsiveness in an experimental model of chronic allergic inflammation in Balb/c mice Source: International Congress 2014 – Animal models in respiratory drug development Year: 2014
Plant proteinase inhibitor from enterolobium contortisiliquum (EcTI ) attenuates elastase-induced pulmonary inflammatory and remodeling alterations in mice Source: Annual Congress 2011 - Recent developments in COPD Year: 2011
Plant proteinase inhibitor from crataeva tapia (CrataBl) attenuates inflammation and remodelling induced by elastase in mice Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013
Efficacy of a novel PI3Kd inhibitor, DS-1515 in animal models of asthma Source: International Congress 2018 – Novel drug targets for asthma and COPD Year: 2018
Plant proteinase from Bauhinia bauhinioides Kallikrein inhibitor (BbKI) attenuates mechanics, inflammation and remodelling induced by elastase in mice Source: Annual Congress 2012 - The many roads to lung injury Year: 2012
Effect of phosphodiesterase 4 (PDE-4) inhibitor – rolipram with or without co-administration of dexamethasone on experimental asthma - guinea pig model Source: Eur Respir J 2004; 24: Suppl. 48, 128s Year: 2004
Effect of a thrombin inhibitor on murine bronchial asthma Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009
Effect of a pan-JAK inhibitor pyridone 6 on airway responses in murine asthma model Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010
Treatment with proteinase inhibitor from Enterolobium contortisiliquum in mice with asthma-COPD Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD Year: 2020
Efficacy of the PDE4 inhibitor, BAY 19-8004, in a smoke-induced model of pulmonary inflammation in the guinea pig Source: Eur Respir J 2001; 18: Suppl. 33, 36s Year: 2001
Identification of wheatsubtilisin/chymotrypsin inhibitor (WSCI) as an important allergen for Baker‘s asthma Source: Eur Respir J 2006; 28: Suppl. 50, 677s Year: 2006
Plant proteinase inhibitor from Enterolobium contortisiliquum (EcTI ) attenuates elastase-induced pulmonary inflammatory, remodeling and mechanical alterations in mice Source: Annual Congress 2012 - The many roads to lung injury Year: 2012
Plant proteinase from bauhinia bauhinioides kallikrein inhibitor (BbKI) attenuates inflammation and remodelling induced by elastase in mice Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014
Treatment with proteinase inhibitor, BbCI, modulates inflammatory response, mechanic alterations, and remodeling on elastase-induced emphysema in mice Source: Annual Congress 2012 - The many roads to lung injury Year: 2012